Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-05-10
2005-05-10
Saunders, David (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C435S021000
Reexamination Certificate
active
06890725
ABSTRACT:
The present invention provides compositions and methods for modulating B-lymphocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating B-lymphocyte activation are provided. Compositions and methods for the treatment of disorders related to dysfunction or dysregulation of B-lymphocyte activation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating B-lymphocyte activation.
REFERENCES:
patent: 5969102 (1999-10-01), Bram et al.
patent: 6160010 (2000-12-01), Uckun et al.
Crozet et al., “Cloning of the Genes Encoding Two Murine and Human Cochlear Uncoventional Type I Myosins”,Genomics40: 332-341 (1997).
Masuda Esteban
Powell Mark
Vallone Marcy K.
Wong Brian R.
Saunders David
Townsend and Townsend / and Crew LLP
LandOfFree
Modulators of B-lymphocyte activation, myosin-1F... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of B-lymphocyte activation, myosin-1F..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of B-lymphocyte activation, myosin-1F... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3451734